- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 64 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- April 2025
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- March 2025
- 186 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- May 2025
- 233 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- May 2025
- 200 Pages
Global
From €2230EUR$2,490USD£1,901GBP
- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- November 2024
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- June 2025
- 277 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2687EUR$3,000USD£2,291GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1344EUR$1,500USD£1,145GBP
- Report
- April 2025
- 205 Pages
Global
From €4474EUR$4,995USD£3,814GBP
- Report
- July 2020
- 280 Pages
Global
From €4388EUR$4,899USD£3,741GBP
- Report
- April 2023
- 35 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- March 2022
- 75 Pages
Global
From €851EUR$950USD£725GBP
From €1971EUR$2,200USD£1,680GBP
- Report
- May 2024
- 131 Pages
Global
From €5821EUR$6,499USD£4,962GBP

The Psychedelic Drug market is a rapidly growing sector of the Mental Disorders Drugs industry. Psychedelic drugs are substances that produce altered states of consciousness, often with spiritual or therapeutic effects. These drugs are being studied for their potential to treat a variety of mental health conditions, including depression, anxiety, PTSD, and addiction.
Psychedelic drugs are being studied in clinical trials and are being used in a variety of therapeutic settings, including psychotherapy, meditation, and yoga. The potential of these drugs to treat mental health conditions has led to a surge in interest in the field, with many companies researching and developing new psychedelic drugs.
Companies in the Psychedelic Drug market include Compass Pathways, Mind Medicine, ATAI Life Sciences, Field Trip Health, and Eleusis Benefit Corporation. These companies are researching and developing new psychedelic drugs, as well as providing therapeutic services and conducting clinical trials. Show Less Read more